Cargando…

Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region

INTRODUCTION: Low Molecular Weight Heparins (LMWHs) and Fondaparinux have been widely used as anticoagulants. Mass prescription may lead to prescriptive inappropriateness, which causes Heparin-induced thrombocytopenia and other side effects. OBJECTIVES: The study investigates the appropriate prescri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moretti, Giaele, Vinci, Bruna, Zito, Simona, Caputo, Alessia, Attanasio, Francesco, Vainieri, Milena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501549/ https://www.ncbi.nlm.nih.gov/pubmed/37708187 http://dx.doi.org/10.1371/journal.pone.0291628

Ejemplares similares

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Monitoring Appropriate Monoclonal Antibodies Prescribing via Administrative Data: An Application to Psoriasis
por: Guidotti, Elisa, et al.
Publicado: (2022)

Regional practice variation in pelvic organ prolapse surgery in Tuscany, Italy: a retrospective cohort study on administrative health data
por: Ferrari, Amerigo, et al.
Publicado: (2023)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Estimating variations in the use of antibiotics in primary care: Insights from the Tuscany region, Italy
por: Willmington, Claire, et al.
Publicado: (2021)

PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis
por: Guidotti, E., et al.
Publicado: (2021)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

Fondaparinux sodium/heparin: Type II heparin-induced thrombocytopenia and drug cross reactivity: case report
Publicado: (2022)

Design of a care pathway for Hepatitis C: a pilot study with three University Hospitals from Tuscany
por: Corazza, I, et al.
Publicado: (2022)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis
por: Kumar, Arun, et al.
Publicado: (2019)

The challenge of community care: evidence from the Family and Community Nurse model in Tuscany
por: Taddeucci, L, et al.
Publicado: (2023)

Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device
por: Velagic, V., et al.
Publicado: (2014)

Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
por: He, Yumiao, et al.
Publicado: (2018)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study
por: Yang, Tianxiang, et al.
Publicado: (2023)

Efficacy and Safety Study of Low-Molecular-Weight Heparin and Fondaparinux Sodium After Hip Arthroplasty: A Retrospective Cohort Study
por: Haibier, Abuduwupuer, et al.
Publicado: (2023)

Changes in Acute Myocardial Infarction, Stroke, and Heart Failure Hospitalizations During COVID-19 Pandemic in Tuscany—An Interrupted Time Series Study
por: Wang, Sophie Y., et al.
Publicado: (2022)

Novel, Precise, Accurate Ion-Pairing Method to Determine the Related Substances of the Fondaparinux Sodium Drug Substance: Low-Molecular-Weight Heparin
por: Deshpande, Amol A., et al.
Publicado: (2016)

Contraception free of charge for young women in Tuscany: an interrupted time series analysis
por: Ferrari, A, et al.
Publicado: (2022)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
por: Christopher, Amy
Publicado: (2016)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study
por: Fu, Donglin, et al.
Publicado: (2022)

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients
por: Benken, Scott T, et al.
Publicado: (2014)

A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux
por: Koul, AN
Publicado: (2015)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases
por: Illuminati, Giulio, et al.
Publicado: (2016)

Tuscany Valley
por: Alexander, Philip
Publicado: (2022)

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making
por: Johnston, Amy, et al.
Publicado: (2018)

Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
por: Ertan-Bolelli, Tugba, et al.
Publicado: (2022)

Novel self assembling nanoparticles for the oral administration of fondaparinux: Synthesis, characterization and in vivo evaluation
por: Ralay-Ranaivo, Bettina, et al.
Publicado: (2014)

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Management of acute coronary syndromes with fondaparinux
por: Wienbergen, Harm, et al.
Publicado: (2007)

Thromboelastographic monitoring of fondaparinux in surgical patients
por: Martinez, B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0t0kp15l7uh2dcjnco66hk29ig